Rule 3 Composition of the statutory committeesI1
England, Wales and Scotland
The Investigating Committee is to consist of—
a lay member who is the chair;
two lay members who are deputy chairs; F1and
not fewer than three and not more than eleven other members who may be lay members or registrant members.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Fitness to Practise Committee is to consist of—
a lay member who is the chair;
not fewer than three and not more than eight lay members who are deputy chairs; and
not fewer than eight and not more than fifty one other members who may be lay members or registrant members.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Appeals Committee is to consist of—
a lay member who is the chair;
two lay members who are deputy chairs; F7and
not fewer than three and not more than seventeen other members who may be lay members or registrant members.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The number of lay members of each committee (including any chair or deputy chair) must be at least the same as the number of registrant members.
The chairs and deputy chairs referred to in paragraphs (1)(a) and (b), (2)(a) and (b) and (3)(a) and (b) may be legally qualified.
In the absence of the chair of a statutory committee at a meeting or hearing, one of the deputy chairs of that committee may perform the functions of the chair.
Annotations
Textual amendments
- F1
Word in Sch. rule 3(1)(b) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(2)(a)
- F2
Sch. rule 3(1)(c) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(2)(b)
- F3
Sch. rule 3(1)(d) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(2)(c)
- F4
Sch. rule 3(2)(b) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(3)(a)
- F5
Sch. rule 3(2)(c) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(3)(b)
- F6
Sch. rule 3(2)(d) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(3)(c)
- F7
Word in Sch. rule 3(3)(b) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(4)(a)
- F8
Sch. rule 3(3)(c) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(4)(b)
- F9
Sch. rule 3(3)(d) repealed (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(4)(c)
- F10
Sch. rule 3(3A) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(5)
Commencement
- I1
Sch. rule 3 in force at 27.9.2010, see Sch. rule 1